Inhibition of luteal function by oxytocin antagonist in goats (Capra hircus)

J Reprod Fertil. 1992 Jan;94(1):279-85. doi: 10.1530/jrf.0.0940279.

Abstract

Early corpus luteum development in nonpregnant and pregnant goats was characterized by a steady increase in peripheral plasma concentrations of progesterone and a high release of prostacyclin (PGI-2) but low release of prostaglandin F-2 alpha (PGF-2 alpha). Jugular administration of oxytocin antagonist (OXA) (0.2 microgram/kg/day) on the day of oestrus and for 3 days thereafter to cyclic and mated goats, significantly (P less than 0.001) inhibited progesterone and prostaglandin secretion and reduced conception rate. Co-administration of PGI-2 (200 micrograms/day) with OXA resulted in a steady increase of progesterone and establishment of pregnancy, but co-administration of PGF-2 alpha (175 micrograms/day) with OXA had no effect. It is suggested that oxytocin is required for early development of the corpus luteum and such effects may be mediated via PGI-2 production.

MeSH terms

  • Animals
  • Corpus Luteum / drug effects*
  • Corpus Luteum / growth & development
  • Corpus Luteum / physiology
  • Depression, Chemical
  • Dinoprost / blood
  • Dinoprost / pharmacology
  • Epoprostenol / blood
  • Epoprostenol / pharmacology
  • Estrus / blood
  • Estrus / drug effects*
  • Female
  • Goats / physiology*
  • Oxytocin / antagonists & inhibitors*
  • Pregnancy
  • Pregnancy, Animal / blood
  • Pregnancy, Animal / drug effects*
  • Progesterone / blood
  • Vasotocin / analogs & derivatives*
  • Vasotocin / pharmacology

Substances

  • Progesterone
  • Oxytocin
  • vasotocin, 1-(beta-mercapto-beta,beta-diethylpropionic acid)-(OEt-Tyr)(2)-Orn(8)-
  • Dinoprost
  • Epoprostenol
  • Vasotocin